LCN2 and coronary artery disorder: Men with CAD had significantly higher serum LCN2 levels than their counterparts without CAD (39.2 (29.3-56.5) vs. 32.7 (20.5-49.7) ng/mL, p < 0.05); however, the CAD-related significant trend was not found among the women (29.0 (18.5-51.9) vs. 27.0 (19.2-40.9) ng/mL, p > 0.05, Figure 1).